美國拋棄式注射器市場規模、佔有率、趨勢分析報告：按產品、按應用、細分市場預測，2024-2030

美國拋棄式注射器市場成長與趨勢

Grand View Research, Inc.的最新報告顯示，到2030年，美國拋棄式注射器市場規模預計將達到36.9億美元。

預測期內複合年成長率預計為 5.5%。除了疫苗需求的增加之外，自我給藥的日益普及、安全注射器的日益普及以及技術的進步正在支持美國拋棄式注射器市場的成長。

SARS-CoV-2 大流行顯著增加了對醫院用品、急救用品、醫療耗材和藥品的需求。由於 COVID-19，COVID-19 疫苗的產量增加，對美國製造的拋棄式注射器的需求也增加。 2020 年 1 月，生物醫學高級研究與開發局 (BARDA) 預測，光在美國就需要 6.5 億至 8.5 億支針頭和注射器用於疫苗接種。因此，COVID-19疫情對醫用拋棄式注射器市場產生了重大影響，被認為是美國拋棄式注射器市場非常有效的促進因素。

展望未來，聯合國兒童基金會 (UNICEF) 等組織的目標是到年終前購買 10 億支注射器，用於在 COVID-19 設施國家進行 COVID-19 疫苗接種工作。所有這些注射器均屬於世界衛生組織 (WHO) 批准的自動失效 (AD) 類型。因此，預計市場成長將在不久的將來加速。

美國拋棄式注射器市場報告亮點

• 依產品分類，拋棄式注射器市場分為傳統注射器和安全注射器。 2023年，安全注射器細分市場佔據最大佔有率，約為64.5%，由於該產品具有安全性和易用性等各種優勢，預計在預測期內將出現顯著成長。
• 依應用來看，由於捐血意識不斷增強，以及國內愛滋病感染疾病、結核瘧疾、登革熱等疾病盛行率上升，治療注射器領域在2023年佔據最大市場佔有率，約86.2%。
• 預計加州拋棄式注射器市場在預測期內將呈現最快的成長速度。促進市場成長的因素包括老年人口的增加、手術數量的增加以及醫療保健支出的增加。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章拋棄式注射器市場變數、趨勢、範圍

• 市場體系展望
  • 母市場展望
  • 配套市場前景
• 滲透率和成長前景圖
• 使用者觀點分析
  • 消費行為分析
  • 市場影響者分析
• 主要最終用戶名單
• 市場動態
  • 市場促進因素分析
  • 市場限制因素分析
• 拋棄式注射器：市場分析工具
  • 產業分析-波特五力分析
  • SWOT 分析，透過 PEST
• COVID-19 對市場的影響和大流行後的前景

第4章美國拋棄式注射器市場：細分分析，按產品，2018-2030

• 定義和範圍
• 2023 年及 2030 年產品市場佔有率分析
• 細分儀表板
• 美國拋棄式注射器市場（按產品），2018-2030
• 2018-2030年市場規模及預測及趨勢分析
• 傳統注射器
• 安全注射器

第5章美國拋棄式注射器市場：細分分析（按應用），2018-2030

• 定義和範圍
• 2023 年和 2030 年應用市場佔有率分析
• 細分儀表板
• 2018-2030 年美國拋棄式注射器市場（按應用）
• 2018-2030年市場規模及預測及趨勢分析
• 疫苗注射
• 治療注射

第6章美國拋棄式注射器市場-競爭分析

• 主要市場參與企業的最新趨勢和影響分析
• 公司分類
  • 創新者
  • 市場領導者
• 供應商情況
• 公司簡介
  • Medtronic
  • Nipro Corporation
  • Fresenius Kabi Ag
  • Baxter International, Inc.
  • Braun Medical, Inc.
  • Becton, Dickinson And Company（Bd）
  • Flextronics International Vita Needle Company
  • Terumo Corporation
  • Novo Nordisk
  • Ultimed, Inc.
  • Henke-sass, Wolf
  • Retractable Technologies, Inc.

U.S. Disposable Syringes Market Growth & Trends:

The U.S. disposable syringes market size is expected to reach USD 3.69 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to register a 5.5% CAGR over the forecast period. The market is expected to grow due to increasing demand for vaccines along with growing adoption of self-administration of drugs, increasing adoption of safety syringes, and technological advancements, are supporting the market growth of U.S. disposable syringes.

The COVID-19 pandemic is anticipated to have a significant effect on the disposable syringe business in the U.S. The SARS-CoV-2 pandemic has caused a considerable increase in demand for hospital supplies, emergency supplies, medical disposables, and medications. Due to COVID-19, there has been an increase in COVID-19 vaccine production, which has led to an increase in demand for disposable syringes made in the U.S. In January 2020, in the U.S. alone, the Biomedical Advanced Research and Development Authority (BARDA) projected that 650 million to 850 million needles and syringes would be required to administer a vaccination. Therefore, the COVID-19 outbreak has immensely impacted medical disposables market and is considered to be a highly effective driver for U.S. disposable syringes market.

Moving forward, organizations like United Nations Children's Fund (UNICEF) aimed to purchase 1 billion syringes by the end of 2021 for COVID-19 vaccination operations in COVAX Facility nations. The syringes will all be of the auto-disable (AD) type, as permitted by the World Health Organization, notwithstanding the fact that the vaccines secured by the Facility may vary in their composition and storage needs. As a result, market growth is expected to accelerate in the near future.

U.S. Disposable Syringes Market Report Highlights:

• On the basis of product, disposable syringes market has been segmented into conventional and safety syringes. Safety syringes segment held the largest share of around 64.5% in 2023 and is anticipated to witness a significant growth over the forecast period, owing to the various advantages, such as safety and easy to use, associated with this product.
• On the basis of application, the therapeutic injection segment held the largest market share of around 86.2% in 2023, owing to the increasing awareness towards blood donation and high prevalence of diseases such as HIV infection, tuberculosis malaria, and dengue in the country.
• California disposable syringes market is expected to witness the fastest growth rate over the forecast period. Factors that can be attributed to market growth include growing geriatric population, increasing number of surgeries, and rising expenditure on healthcare.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation And Scope
  • 1.1.1 Product
  • 1.1.2 Application
  • 1.1.3 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database:
  • 1.3.2 Gvr's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Details Of Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.7.1 Commodity Flow Analysis (Model 1)
    • 1.7.1.1 Approach 1: Commodity Flow Approach
  • 1.7.2 Volume Price Analysis (Model 2)
    • 1.7.2.1 Approach 2: Volume Price Analysis
• 1.7 List Of Secondary Sources
• 1.8 List Of Primary Sources
• 1.9 List Of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective - 1
  • 1.10.2 Objective - 2
  • 1.10.3 Objective - 3
  • 1.10.4 Objective - 4

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Segment Outlook
• 2.3 Competitive Insights

Chapter 3 Disposable Syringes Market Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market Outlook
• 3.2 Penetration & Growth Prospect Mapping
• 3.3 User Perspective Analysis
  • 3.3.1 Consumer Behavior Analysis
  • 3.3.2 Market Influencer Analysis
• 3.4 List Of Key End Users
• 3.5 Market Dynamics
  • 3.5.1 Market Driver Analysis
    • 3.5.1.1 Increase In The Prevalence Of Chronic Diseases
    • 3.5.1.2 Increase In The Number Of Surgical Procedures
    • 3.5.1.3 Impact Of Covid-19 Outbreak
    • 3.5.1.4 Increasing Initiatives By Governments And Organizations
  • 3.5.2 Market Restraints Analysis
    • 3.5.2.1 Stringent Government Regulations
    • 3.5.2.2 Product Recalls
• 3.6 Disposable Syringes: Market Analysis Tools
  • 3.6.1 Industry Analysis - Porter's Five Forces
  • 3.6.2 Swot Analysis, By Pest
• 3.7 Impact Of Covid-19 On Market & Post Pandemic Insights

Chapter 4 U.S. Disposable Syringes Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)

• 4.1 Definition And Scope
• 4.2 Product Market Share Analysis, 2023 & 2030
• 4.3 Segment Dashboard
• 4.4 U.S. Disposable Syringes Market, By Product, 2018 To 2030
• 4.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
  • 4.5.1 Conventional Syringes
    • 4.5.1.1 Conventional Syringes Market, 2018 - 2030 (USD Million)
  • 4.5.2 Safety Syringes
    • 4.5.2.1 Safety Syringes Market, 2018 - 2030 (USD Million)
    • 4.5.2.1.1 Retractable Safety Syringes
    • 4.5.2.1 1.1 Retractable Safety Syringes Market, 2018 - 2030 (USD Million)
    • 4.5.2.1.2 Non-retractable Safety Syringes
    • 4.5.2.1.2.1 Non-retractable Safety Syringes Market, 2018 - 2030 (USD Million)

Chapter 5 U.S. Disposable Syringes Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

• 5.1 Definition And Scope
• 5.2 Application Market Share Analysis, 2023 & 2030
• 5.3 Segment Dashboard
• 5.4 U.S. Disposable Syringes Market, By Application, 2018 To 2030
• 5.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
  • 5.5.1 Immunization Injections
    • 5.5.1.1 Immunization Injections Market, 2018 - 2030 (USD Million)
  • 5.5.2 Therapeutic Injections
    • 5.5.2.1 Therapeutic Injections Market, 2018 - 2030 (USD Million)

Chapter 6 U.S. Disposable Syringes Market - Competitive Analysis

• 6.1 Recent Developments & Impact Analysis, By Key Market Participants
• 6.2 Company Categorization
  • 6.2.1 Innovators
  • 6.2.2 Market Leaders
• 6.3 Vendor Landscape
  • 6.3.1 Key Company Market Share Analysis, 2021
  • 6.3.2 Major Deals And Strategic Alliances
    • 6.3.2.1 New Product Launch
    • 6.3.2.2 Expansion
    • 6.3.2.3 Acquistion
  • 6.3.3 Market Entry Strategies
• 6.4 Company Profiles
  • 6.4.1 Medtronic
    • 6.4.1.1 Company Overview
    • 6.4.1.2 Financial Performance
    • 6.4.1.3 Product Benchmarking
    • 6.4.1.4 Strategic Initiatives
  • 6.4.2 Nipro Corporation
    • 6.4.2.1 Company Overview
    • 6.4.2.2 Financial Performance
    • 6.4.2.3 Product Benchmarking
    • 6.4.2.4 Strategic Initiatives
  • 6.4.3 Fresenius Kabi Ag
    • 6.4.3.1 Company Overview
    • 6.4.3.2 Financial Performance
    • 6.4.3.3 Product Benchmarking
    • 6.4.3.4 Strategic Initiatives
  • 6.4.4 Baxter International, Inc.
    • 6.4.4.1 Company Overview
    • 6.4.4.2 Financial Performance
    • 6.4.4.3 Product Benchmarking
    • 6.4.4.4 Strategic Initiatives
  • 6.4.5 Braun Medical, Inc.
    • 6.4.5.1 Company Overview
    • 6.4.5.2 Financial Performance
    • 6.4.5.3 Product Benchmarking
    • 6.4.5.4 Strategic Initiatives
  • 6.4.6 Becton, Dickinson And Company (Bd)
    • 6.4.6.1 Company Overview
    • 6.4.6.2 Financial Performance
    • 6.4.6.3 Product Benchmarking
    • 6.4.6.4 Strategic Initiatives
  • 6.4.7 Flextronics International Vita Needle Company
    • 6.4.7.1 Company Overview
    • 6.4.7.2 Financial Performance
    • 6.4.7.3 Product Benchmarking
    • 6.4.7.4 Strategic Initiatives
  • 6.4.8 Terumo Corporation
    • 6.4.8.1 Company Overview
    • 6.4.8.2 Financial Performance
    • 6.4.8.3 Product Benchmarking
    • 6.4.8.4 Strategic Initiatives
  • 6.4.9 Novo Nordisk
    • 6.4.9.1 Company Overview
    • 6.4.9.2 Financial Performance
    • 6.4.9.3 Product Benchmarking
    • 6.4.9.4 Strategic Initiatives
  • 6.4.10 Ultimed, Inc.
    • 6.4.10.1 Company Overview
    • 6.4.10.2 Financial Performance
    • 6.4.10.3 Product Benchmarking
    • 6.4.10.4 Strategic Initiatives
  • 6.4.11 Henke-sass, Wolf
    • 6.4.11.1 Company Overview
    • 6.4.11.2 Financial Performance
    • 6.4.11.3 Product Benchmarking
  • 6.4.12 Retractable Technologies, Inc.
    • 6.4.12.1 Company Overview
    • 6.4.12.2 Financial Performance
    • 6.4.12.3 Product Benchmarking
    • 6.4.12.4 Strategic Initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. disposable syringes market, by product, 2018 - 2030 (USD Million)
• Table 4 U.S. disposable syringes market, by application, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Disposable syringes market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2021)
• Fig. 10 Segment outlook
• Fig. 11 Strategy framework
• Fig. 12 Penetration & growth prospect mapping
• Fig. 13 Consumer behavior analysis
• Fig. 14 Market driver relevance analysis (Current & future impact)
• Fig. 15 Market restraint relevance analysis (Current & future impact)
• Fig. 16 Porter's five forces analysis
• Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 18 Disposable syringes market: Product movement analysis
• Fig. 19 Segment dashboard
• Fig. 20 Disposable syringes market product outlook: Key takeaways
• Fig. 21 Conventional syringes market, 2018 - 2030 (USD Million)
• Fig. 22 Safety syringes market, 2018 - 2030 (USD Million)
• Fig. 23 Retractable safety syringes market, 2018 - 2030 (USD Million)
• Fig. 24 Non-retractable safety syringes market, 2018 - 2030 (USD Million)
• Fig. 25 Disposable syringes market: Application movement analysis
• Fig. 26 Segment dashboard
• Fig. 27 Disposable syringes market application outlook: Key takeaways
• Fig. 28 Immunization injections market, 2018 - 2030 (USD Million)
• Fig. 29 Therapeutic injections market, 2018 - 2030 (USD Million)
• Fig. 30 Company market share analysis, 2021
• Fig. 31 Market differentiators